Chemokines in the corpus luteum: Implications of leukocyte chemotaxis by Townson, David H & Liptak, Amy R
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Reproductive Biology and 
Endocrinology
Open Access Review
Chemokines in the corpus luteum: Implications of leukocyte 
chemotaxis
David H Townson* and Amy R Liptak
Address: Department of Animal and Nutritional Sciences, University of New Hampshire-Durham, Durham, NH 03824, USA
Email: David H Townson* - dave.townson@unh.edu; Amy R Liptak - JAJliptak@aol.com
* Corresponding author    
Abstract
Chemokines are small molecular weight peptides responsible for adhesion, activation, and
recruitment of leukocytes into tissues. Leukocytes are thought to influence follicular atresia,
ovulation, and luteal function. Many studies in recent years have focused attention on the
characterization of leukocyte populations within the ovary, the importance of leukocyte-ovarian
cell interactions, and more recently, the mechanisms of ovarian leukocyte recruitment. Information
about the role of chemokines and leukocyte trafficking (chemotaxis) during ovarian function is
important to understanding paracrine-autocrine relationships shared between reproductive and
immune systems. Recent advances regarding chemokine expression and leukocyte accumulation
within the ovulatory follicle and the corpus luteum are the subject of this mini-review.
Introduction
Leukocyte recruitment and activation within the ovary are
thought to play important roles in follicular atresia, ovu-
lation, and luteal function [1-6]. Consequently, many
studies concerning ovarian function within the past sev-
eral years have focused on characterizing leukocyte popu-
lations within the ovary, understanding further the
importance of leukocyte-ovarian cell interactions, and
more recently, discerning the mechanisms of ovarian leu-
kocyte recruitment. The existence of specific subsets of
leukocytes (e.g., monocytes-macrophages, T-lym-
phocytes, eosinophils, etc.) and their fluctuation in
number within the ovary during select stages of ovarian
function are currently well-documented [7-15]. Leuko-
cytes and their secretory products are thought to influence
ovarian function by acting as local mediators of follicular
atresia, ovulation, and luteolysis [16-20]. The observation
that leukocytes accumulate only within certain structures
of the ovary, suggests that these cells migrate from the
bloodstream in response to specific, unidirectional chem-
oattractant cues. The discovery and characterization of an
ever-expanding family of molecules specialized to attract
leukocytes, called chemokines, has led to a renewed inter-
est among reproductive biologists concerning the impor-
tance of leukocyte trafficking within the ovary. This mini-
review focuses primarily on recent advances relative to
chemokine expression and leukocyte recruitment during
the periovulatory period, luteinization, and during regres-
sion of the corpus luteum.
Classification of chemokines
Chemokines are small molecular weight peptides respon-
sible for adhesion, activation, and chemotaxis of leuko-
cytes [21]. Chemokines are structurally related, possessing
a pattern of conserved cysteine residues near the amino-
terminal domain. It is the position of these cysteine resi-
dues that is the basis for the classification of chemokines
into four families (see Table 1). The -CXC-, or alpha
chemokine family, has one amino acid (X) separating two
of four conserved cysteine residues. A well-characterized
Published: 10 November 2003
Reproductive Biology and Endocrinology 2003, 1:94
Received: 14 April 2003
Accepted: 10 November 2003
This article is available from: http://www.rbej.com/content/1/1/94
© 2003 Townson and Liptak; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted 
in all media for any purpose, provided this notice is preserved along with the article's original URL.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/94
Page 2 of 7
(page number not for citation purposes)
chemokine of this family is interleukin-8 (IL-8), which is
often expressed by endothelial cells to attract neutrophils.
Conversely, the -CC-, or beta family of chemokines has
two adjacent cysteine residues. A representative chemok-
ine of this family is monocyte chemoattractant protein-1
(MCP-1), a potent chemotactic molecule that elicits
monocyte and T-lymphocyte recruitment [22].
Two relatively new chemokine families have been identi-
fied, the -C- family and -CX3C-family. Lymphotactin, a
member of the -C-chemokine family, has only one
Table 1: Summary of Select Chemokines
-CXC-Chemokines
Chemokine Source Primary Target Receptor
BCA-1 lymphoid tissue B-lymphocytes CXCR5
ENA-78 epithelial cells neutrophils CXCR2
GCP-2 granulocytes neutrophils CXCR1
GRO-αβγ endothelial cells, fibroblasts, monocytes, 
macrophages
neutrophils CXCR2
IL-8 macrophages, endothelial cells neutrophils, basophils, T-lymphocytes, epithelial cells, 
macrophages
CXCR1, R2
IP-10 monocytes T-lymphocytes, TIL, endothelial cells, NK cells CXCR3
MIG monocytes, macrophages T-lymphocytes, TIL CXCR3
SDF-1α, 1β stromal cells hematopoietic cells CXCR4
-CC-Chemokines
Chemokine Source Primary Target Receptor
Eotaxin monocytes eosinophils CCR3
Exodus-1 neutrophils, peripheral blood 
lymphocytes
T-lymphocytes, NK cells CCR6
MCP-1 endothelial cells, monocytes, 
macrophages, fibroblasts
monocytes, basophils NK cells, T-lymphocytes CCR2, R4, R10
MCP-2 monocytes, macrophages monocytes, basophils, eosinophils, NK cells, T-
lymphocytes
CCR1, R2, R3 R10
MCP-3 monocytes, macrophages monocytes, basophils, eosinophils, NK cells, T-
lymphocytes, dendritic cells
CCR1, R2 R3, R10
MCP-4 endothelial cells, monocytes, 
macrophages
monocytes, T-lymphocytes, eosinophils CCR3
MIP-1α monocytes, T-lymphocytes, neutrophils monocytes, T-lymphocytes, NK cells, basophils, 
eosinophils, dendritic cells
CCR1, R4,
MIP-1β monocytes, neutrophils monocytes, T-cells, NKs, dendritic cells CCR5
MIP-5 monocytes monocytes, eosinophils, basophils CCR1, R3
RANTES T-lymphocytes T-lymphocytes, NK cells, basophils, eosinophils, 
dendritic cells
CCR1, R3, R4, R5, R10
TARC monocytes, thymus tissue T-lymphocytes CCR4
-C-Chemokine
Chemokine Source Primary Target Receptor
Lymphotactin T-lymphocytes, NK cells T-lymphocytes, B-lymphocytes, neutrophils, NK cells XCR1
-CX3C-Chemokine
Chemokine Source Primary Target Receptor
Fractalkine macrophages, dendritic cells, epithelial 
cells
NK cells CX3CR1
BCA = B-cell Attracting Chemokine; ENA = Epithelial-cell-derived Neutrophil-Activating protein; GCP = Granulocyte Chemotactic Peptide; GRO 
= Growth-Related Oncogene; IL = Interleukin; IP = Interferon-gamma-inducible Protein; MCP = Monocyte Chemoattractant Protein; MIG = 
Monokine induced by Interferon-Gamma; MIP = Macrophage Inflammatory Protein; NAP = Neutrophil-Activating Protein; NK = Natural Killer cells; 
RANTES = Regulated upon Activation, Normal T-cell Expressed and Secreted; SDF = Stromal-Derived Factor; TARC = Thymus- and Activation-
Regulated Chemokine; TIL = Tumor-Infiltrating Lymphocytes.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/94
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conserved cysteine residue and predominantly attracts
lymphocytes. The -CX3C-chemokine, fractalkine, has
three amino acids separating two of four cysteines and
attracts natural killer cells. Interestingly, fractalkine is a
membrane-bound protein that may be cleaved, leaving a
functional adhesion molecule and releasing the soluble
chemokine [23].
Chemokines activate G protein-mediated signal transduc-
tion cascades by signaling through seven-transmembrane
receptors [24,25]. Chemokine receptor families are gener-
ally categorized according to their corresponding ligand
family (i.e., CXCR, CCR, XCR and CX3CR receptors corre-
spond with -CXC-, -CC-, -C-, and -CX3C-chemokines,
respectively; see Table 1). Although chemokine-receptor
interactions are specific within families, many chemok-
ines bind to more than one type of receptor, and most
receptors bind several different chemokines (see Table 1).
Thus, leukocytes may exhibit varying patterns of chemok-
ine receptors. For example, neutrophils express receptors
from the CXCR family, while T-lymphocytes express
receptors from both CXCR and CCR families (Table 1).
Moreover, resting T-lymphocytes express only a couple of
chemokine receptors, whereas activated T-lymphocytes
display many. All chemokines have two key regions
within their structure that are necessary for interaction
with their corresponding receptors (Figure 1). The first is
a loop within the peptide backbone stretching between
the second and third cysteine residues. This loop region
initiates binding to the receptor, allowing then for proper
presentation of the second key region, a domain within
the amino-terminus (Figure 1). Together, these regions of
the chemokine molecule trigger receptor activation [24].
Chemokines of the periovulatory period
Leukocyte chemoattractant activity within the ovary was
discovered initially in follicular fluid of ovulatory follicles
[26-29]. Murdoch and McCormick [3,30] reported that
periovulatory follicles secrete low molecular weight fac-
tors, 15–16 amino acids in length, capable of stimulating
leukocyte migration in vitro. Of particular interest in these
studies was the finding that subsets of leukocytes migrated
in a temporal manner. That is, neutrophils and eosi-
nophils were attracted to conditioned medium from fol-
licular tissue obtained 24 and 36 hours after the LH surge;
whereas monocytes migrated only in response to tissues
from the 36-hour time point (approximately 12 hours
after the occurrence of ovulation). Basophils and lym-
phocytes did not exhibit chemotaxis. A similar pattern of
neutrophilic and/or eosinophilic chemotaxis at ovula-
tion, followed by monocyte-macrophage chemotaxis dur-
ing luteinization, occurs in other mammalian species,
including humans [8,10,31-34]. Neutrophilic chemok-
ines, interleukin-8 (IL-8) and growth related oncogene
(GRO), and eosinophilic chemokines, eotaxin and
RANTES (regulated upon activation, normal T-cell
expressed and secreted) are all expressed by ovulatory fol-
licles [35-44]. Similarly, monocyte chemoattractant pro-
tein-1 (MCP-1), a chemokine specific for monocytes and
T-lymphocytes, is expressed during ovulation and the for-
mation of the corpus luteum [42,45]. Collectively, these
observations are consistent with the concept that specific
leukocyte subsets are recruited to play a role in the process
of ovulation and luteinization.
At present, there is limited information available about
the hormonal regulation and temporal expression of
chemokines during the periovulatory period. Chemok-
ines from all four families are transcribed within follicles
of rats following treatment with eCG and hCG [42]. How-
ever, this gonadotropin effect on chemokine expression is
possibly due to the actions of hCG alone. Ushigoe and co-
workers [41] determined that GRO expression in the rat
ovary is stimulated by hCG, but not eCG. Similar findings
of hCG-stimulated, chemokine expression have been
reported in follicles of human and rabbit ovaries
[35,37,39,45]. Neutrophilic chemokine expression occurs
Schematic representation of the four chemokine families Figure 1
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initially within the thecal layer of the follicle, and then
progresses to the granulosal-lutein layer as ovulation
becomes imminent [35,37,39,45]. Chemokine expression
within follicles probably results from an indirect effect of
hCG. Gonadotropins induce the expression of inter-
leukin-1β (IL-1β) and tumor necrosis factor-α (TNFα) in
preovulatory follicles [46]. Chemokine expression by the-
cal and granulosal-lutein cells in culture is stimulated
directly by IL-1β and TNFα [35,37,39,45]. Hence, gona-
dotropin-stimulated chemokine expression within folli-
cles is likely mediated by IL-1β and TNFα effects. Similar
actions of gonadotropins and cytokines would be
expected to establish the recruitment of eosinophils and
monocytes as described in other species [3,13,33,34,43-
45], but the regulatory aspects have not been fully eluci-
dated. Importantly, neutrophilic and eosinophilic chem-
otaxis into the follicle occurs prior to extravasation of red
blood cells and vascular damage [47]. As a consequence of
recruitment and activation, neutrophils and eosinophils
release proteolytic enzymes, cytokines, and other media-
tors that may be involved in aspects of ovulation and
luteinization. Monocytes most likely engage in similar
activities, including the possible expression of IL-8 to
attract additional neutrophils [35,45].
The influence of ovarian steroids on chemokine expres-
sion during the periovulatory period is controversial. In
two recent studies it was determined that estradiol and
progesterone do not affect chemokine (IL-8 & GRO)
expression in ovarian tissue [40,41]. These results are in
contrast to work by Arici and co-workers [35], who con-
cluded that progesterone suppresses both basal and IL-1α-
stimulated IL-8 expression in cultures of ovarian stromal
and granulosal-lutein cells. Considering that many of the
chemokines are regulated through the common pathway
of NF-kappa B activation [48], it is plausible that ovarian
steroids influence chemokine expression through tran-
scriptional regulation. Further work is needed to define
the temporal and hormonal regulation of chemokine
expression during the periovulatory period, especially the
effects of cytokines and ovarian steroids. Moreover, there
have been no studies to our knowledge that have investi-
gated whether or not steroidogenic cells of the ovary
respond to chemokines directly, or for that matter, possess
chemokine receptors. In contrast, there is evidence that
Leydig cells of the testis express the -CXC-chemokine,
interferon-gamma-inducible protein 10 (IP-10), and that
IP-10 inhibits basal and hCG-induced testosterone pro-
duction [49].
Chemokine expression within the ovulatory follicle could
have important physiological implications. Diminished
ovulation rates have been reported in animals depleted of
neutrophils [39,50]; whereas the addition of peripheral
blood leukocytes to in vitro-perfused rat ovaries increases
the number of LH-induced ovulations [6]. In other stud-
ies, ovulation rate is unaffected by depletion of leukocytes
[51,52], but development and function of the corpus
luteum is impaired [53-55]. Thus, whether chemokines,
leukocyte chemotaxis, and leukocytes are indispensable to
ovulation remains controversial, but these factors may
contribute to aspects of luteinization and the early devel-
opment of the corpus luteum.
The influence of chemokines on luteinization has not
been studied extensively, but may be related to promoting
neovascularization, similar to the effects of vascular
endothelial growth factor (VEGF) [56-58]. Several -CXC-
chemokines, including IL-8 and GRO, have potent ang-
iogenic properties distinct from their ability to attract leu-
kocytes and promote inflammation [59]. Of the -CC-
chemokines, MCP-1 has been characterized as a potent
angiogenic molecule in corneal angiogenesis and collat-
eral vessel formation [60,61], but initial evidence indi-
cates that MCP-1 does not promote vascularization of the
corpus luteum [61]. In addition to the potential ang-
iogenic effects of chemokines, eosinophils have been
recently implicated as a source of VEGF in the developing
corpus luteum [54]. Thus, the combined actions of chem-
okines and leukocytes might encourage neovasculariza-
tion during luteal development.
The consequences of genetic deletion of chemokines or of
similar chemotactic molecules during the folliculo-luteal
transition have been examined directly in only a few stud-
ies [55,62-64]. Experiments with genetic knock-out mice
have not resolved whether or not the absence of a single
chemokine impairs ovulation and luteal function [55,62-
64]. The inherent redundancy of chemokine expression in
tissues might be a confounding issue in these studies.
Multiple chemokines are often expressed in response to a
single stimulus (e.g., the induction of IL-8, GRO, and
MCP-1 in follicles by hCG), and might provide for over-
lapping influences. Such redundant pathways serve to
optimize error-free information transmission. However,
within this redundancy are elements of specificity, includ-
ing the hormonal microenvironment (e.g., chemokine
concentration) and the temporal pattern and cellular
source(s) of chemokine/receptor expression. An emerging
view of chemokine action is that distinct networks of cells
interact through production of specific chemokines and/
or the expression of a highly unique pattern of chemokine
receptors [21]. Thus, future work determining the role and
physiological implications of chemokines during ovula-
tion and luteinization should consider these emerging
concepts.
Chemokines of the regressing corpus luteum
The accumulation of leukocytes, particularly monocytes-
macrophages, within the regressing corpus luteum is well-Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/94
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documented, but only recently have investigators consid-
ered that this accumulation might result from chemokine
expression. Monocyte chemoattractant protein-1 (MCP-
1), a potent and monocyte-specific peptide, was the first
identified and is currently the most studied chemokine
involved in the process of luteal regression. Hosang and
co-workers determined that porcine luteal tissue contains
mRNA for MCP-1 and -2 [65,66]. This initial discovery
was followed quickly by studies documenting that MCP-1
expression occurs prior to and during luteal regression
[67], is induced by luteolytic hormones [68-70], and is
accompanied by an accumulation of monocytes-macro-
phages within the corpus luteum [67]. Similar increases in
MCP-1 expression and monocyte-macrophage accumula-
tion during luteal regression have been observed in a vari-
ety of mammalian species [15,71,72] such that increased
MCP-1 expression is now viewed as an indicator of the
luteolytic process [19,20,73,74].
Identifying the cellular sources and regulation of MCP-1
within the corpus luteum has been the focus of recent
investigations. Endothelial cells of the corpus luteum are
clearly a source of MCP-1 [15,61,71,75] and as expected,
proinflammatory cytokines such as TNFα and interferon-
gamma directly stimulate MCP-1 production [75]. How-
ever, progesterone and prostaglandin F2α (PGF) do not
affect endothelial cell secretion of MCP-1 [75]. How then
does PGF-induced luteal regression in the cow and ewe
result in an increase in MCP-1 expression [70,76]? One
possibility is that other cell types within the corpus
luteum (e.g., T-lymphocytes, monocytes-macrophages,
steroidogenic cells, fibroblasts) respond to PGF and
secrete MCP-1. T-lymphocytes are a potential source of
MCP-1 within the corpus luteum [77], but the responsive-
ness of T-lymphocytes to PGF has not been determined.
Large steroidogenic luteal cells possess PGF receptors, but
their capacity to synthesize MCP-1 is controversial
[69,70,78]. Another possibility is that endothelial cells of
the corpus luteum express MCP-1 in response to factors
produced by other PGF-sensitive cells (e.g., steroidogenic
cells, immune cells). In addition to cytokines, other fac-
tors that provoke MCP-1 expression include oxygen-
derived free radicals, Fas-ligand [79,80], and metabolites
of apoptosis. In a very recent study, the onset of luteal cell
apoptosis was proposed to activate MCP-1 gene expres-
sion in adjacent, non-apoptotic cells of the corpus luteum
[78]. Specifically, the process is thought to be Fas-ligand/
Fas mediated, in which luteal cells undergoing Fas-ligand
induced apoptosis stimulate MCP-1 expression in non-
apoptotic cells: MCP-1 then attracts monocytes-macro-
phages to the corpora lutea containing apoptotic cells,
and the apoptotic cells are selectively removed by phago-
cytosis. These concepts are intriguing, and are completely
consistent with the recently hypothesized 'nurturing role'
of immune cells in luteal regression (i.e., to diminish an
inflammatory condition resulting from dead and dying
cells) proposed by Pate and Keyes [19]. Hence, future
research should focus on the importance of cell-cell inter-
actions during luteal regression, and the relationships
among PGF, Fas, chemokines (especially MCP-1), and
apoptosis within the corpus luteum.
Aside from MCP-1, there is very little information availa-
ble about other chemokines expressed during luteal
regression. Endothelial cells of the bovine corpus luteum
express RANTES, and this expression is elevated in
response to TNFα [81]. The ovine corpus luteum produces
chemoattractant(s) for eosinophils following treatment of
ewes with PGF [2], but a specific chemokine has not been
identified. Eosinophils accumulate within the corpus
luteum prior to functional and structural manifestations
of regression [2], but are not considered essential to lute-
olysis despite their capacity to affect tissue structure and
inflammatory events [51]. The equine corpus luteum also
secretes chemoattractant(s) for leukocytes in late diestrus
(before a decline in progesterone secretion), and through-
out spontaneous and PGF-induced luteal regression [82].
Recent evidence of chemokine expression and leukocyte
accumulation within the corpus luteum prior to regres-
sion in these and other studies [15,67,77] infers that
chemokines might be a contributing cause rather than
effect of luteolysis. Moreover, the observation that rescue
of the corpus luteum during simulated early pregnancy is
associated with a diminished accumulation of luteal mac-
rophages [83] indicates that leukocyte-ovarian cell inter-
actions may be of fundamental importance to a variety of
reproductive states. Further examination of chemokine
expression and leukocyte accumulation within the corpus
luteum during luteal regression and during early preg-
nancy is warranted.
Conclusion
The discovery and characterization of an ever-growing
family of chemokines over the past two decades has
prompted renewed interest in leukocyte trafficking during
ovarian function. Chemokines are expressed within ovu-
latory follicles and within the corpus luteum, predomi-
nantly during luteal regression. Chemokine expression in
these ovarian structures is regulated in part by hormones
of reproductive function (e.g., gonadotropins, PGF) and
immune response (e.g., TNFα, IL-1β), and is associated
with the accumulation of select subsets of leukocytes (e.g.,
neutrophils, eosinophils, monocytes). Future work
should focus further on the physiological implications of
chemokines and leukocytes in ovarian function, espe-
cially the role of these elements in ovulation, luteal regres-
sion, and other aspects of ovarian function that have not
received as much attention (i.e., follicular atresia and
maternal rescue of the corpus luteum). This will provideReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/94
Page 6 of 7
(page number not for citation purposes)
important and new insight about relationships shared
between reproductive and immune systems.
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